Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dodick

Showing results (571-580 of 621) with videos related to

Pageof 63
Sort By:
Headache|May 19, 2004
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraineDavid Dodick, Richard B Lipton, Vincent Martin, et al.
Cephalalgia : an International Journal of Headache|March 6, 2018
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)Amaal J Starling, Stewart J Tepper, Michael J Marmura, et al.
Neurology|June 13, 2001
A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritisJ H Noseworthy, P C O'Brien, T M Petterson, et al.
Headache|February 15, 2013
Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative reviewAndrew Blumenfeld, Avi Ashkenazi, Uri Napchan, et al.
The New England Journal of Medicine|July 11, 2019
Trial of Galcanezumab in Prevention of Episodic Cluster HeadachePeter J Goadsby, David W Dodick, Massimo Leone, et al.
Cephalalgia : an International Journal of Headache|May 15, 2021
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraineCristina Tassorelli, Hans-Christoph Diener, Stephen D Silberstein, et al.
Science Translational Medicine|February 7, 2020
The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in femalesYanxia Chen, Aubin Moutal, Edita Navratilova, et al.
Cephalalgia : an International Journal of Headache|April 6, 2017
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine preventionJennifer Y Xie, Milena De Felice, Caroline M Kopruszinski, et al.
Cephalalgia : an International Journal of Headache|May 12, 2006
New appendix criteria open for a broader concept of chronic migraine, J Olesen, M-G Bousser, et al.
Headache|March 11, 2023
Patient-reported experiences with migraine-related cognitive symptoms: Results of the MiCOAS qualitative studyMaya T Gerstein, R J Wirth, Alyssa A Uzumcu, et al.
Pageof 63

Showing results (571-580 of 621) with videos related to

Sort By:
Pageof 63
Headache|May 19, 2004
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraineDavid Dodick, Richard B Lipton, Vincent Martin, et al.
Cephalalgia : an International Journal of Headache|March 6, 2018
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)Amaal J Starling, Stewart J Tepper, Michael J Marmura, et al.
Neurology|June 13, 2001
A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritisJ H Noseworthy, P C O'Brien, T M Petterson, et al.
Headache|February 15, 2013
Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative reviewAndrew Blumenfeld, Avi Ashkenazi, Uri Napchan, et al.
The New England Journal of Medicine|July 11, 2019
Trial of Galcanezumab in Prevention of Episodic Cluster HeadachePeter J Goadsby, David W Dodick, Massimo Leone, et al.
Cephalalgia : an International Journal of Headache|May 15, 2021
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraineCristina Tassorelli, Hans-Christoph Diener, Stephen D Silberstein, et al.
Science Translational Medicine|February 7, 2020
The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in femalesYanxia Chen, Aubin Moutal, Edita Navratilova, et al.
Cephalalgia : an International Journal of Headache|April 6, 2017
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine preventionJennifer Y Xie, Milena De Felice, Caroline M Kopruszinski, et al.
Cephalalgia : an International Journal of Headache|May 12, 2006
New appendix criteria open for a broader concept of chronic migraine, J Olesen, M-G Bousser, et al.
Headache|March 11, 2023
Patient-reported experiences with migraine-related cognitive symptoms: Results of the MiCOAS qualitative studyMaya T Gerstein, R J Wirth, Alyssa A Uzumcu, et al.
Pageof 63